World Health Assembly Resolution On COVID-19 Response: The Stark Choices Faced In A Polarized World Of Global Health 08/05/2020 Svĕt Lustig Vijay & Elaine Ruth Fletcher As the 73rd World Health Assembly approaches, the European Union-sponsored draft resolution on the COVID-19 response is gathering steam and storm as it rolls closer to the planned opening of the Assembly on 18 May – with far less clarity about how it might actually hit the shores of the public debate. The resolution aims […] Continue reading -> United Nations Approves Second COVID-19 Resolution; Stresses Global Collaboration On R&D, Medicines and Equipment Access 21/04/2020 Editorial team The UN General Assembly approved a resolution Monday night calling for accelerated scientific cooperation and global coordination to hasten the “rapid development, manufacturing and distribution of diagnostics, anti-viral medicines, personal protective equipment and vaccines” needed to fight the COVID-19 pandemic. The resolution, approved in a virtual poll, also called on countries “to immediately take steps […] Continue reading -> Access To Affordable Biologics In The Context Of COVID-19: Will WHO Step Up To Its Responsibility? 14/04/2020 Chetali Rao & K M Gopakumar New Delhi, India – COVID-19 has posed unique challenges for healthcare providers across the globe, as the world has been grappling with the pandemic with no approved treatments or vaccines for the disease. Researchers are searching everywhere for drugs that may help treat or prevent the spread of the deadly virus. This has led to […] Continue reading -> COVID-19 Testing Trends – Globally & Regionally 30/03/2020 Svĕt Lustig Vijay Testing: the crux of effective outbreak responses Testing is an essential component of effective outbreak responses. Without widespread testing, we cannot know whether a disease is spreading nor take measures to appropriately respond to it. “All countries should be able to test all suspected cases, they cannot fight this pandemic blindfolded, they should know where […] Continue reading -> WHO Director General ‘Welcomes’ Costa Rica Call For Pooled Rights To COVID-19 Treatments; G-20 Pledges Broad Support To Emergency Response 26/03/2020 Elaine Ruth Fletcher World Health Organization Director General, Dr Tedros Adhanom Ghebreyesus has welcomed the call by Costa Rica’s President, Carlos Alvarado Quesada, for WHO to launch an initiative that would “pool rights to technologies that are useful for the detection, prevention, control and treatment of the COVID-19 pandemic.” “I welcome his initiative & call for pooled rights […] Continue reading -> Testing For Coronavirus – Can Latin America and Africa Build Upon The Asian Model? 25/03/2020 Svĕt Lustig Vijay & Elaine Ruth Fletcher In normal times, Diego Zapata, undersecretary in the City of Medellin’s Mobility Department, worries about how to advance better public transit systems, cycling and pedestrian networks – to get more people moving around the city. But recently, he and his boss Carlos Cadena began supporting the City’s Health Department in its scramble to reduce travel […] Continue reading -> Costa Rica Urges WHO To Lead Global Initiative For Pooled Rights To COVID-19 Diagnostics, Drugs & Vaccines 24/03/2020 Elaine Ruth Fletcher & Svĕt Lustig Vijay Costa Rica’s president, Carlos Alvarado Quesada has appealed to Dr Tedros Adhanom Ghebreyesus, Director General of the World Health Organization, to “pool rights to technologies that are useful for the detection, prevention, control and treatment of the COVID-19 pandemic”. The presidential letter dated Monday, 23 March, and co-signed by Minister of Health, Daniel Salas Peraza, […] Continue reading -> New COVID-19 Diagnostics Offer Hope – But “Broadbased Testing Not Possible” Says Roche Industry Leader 19/03/2020 Elaine Ruth Fletcher & Svĕt Lustig Vijay New high-throughput test technologies that can process thousands of COVID-19 samples a day are coming online. But the CEO of Roche Pharmaceuticals, which recently gained US Food and Drug Administration approval for a new high-volume test, asserted Thursday that “broad-based testing is simply not feasible.” Severin Schwan, Roche CEO, was speaking at a press conference […] Continue reading -> Costs Of COVID-19 Tests Could Be Limiting Scale-Up in Europe; WHO Says ‘Herd Immunity’ Approach Lacks Evidence Base 17/03/2020 Elaine Ruth Fletcher & Grace Ren A leading medicines access group in Europe has issued a protest against the high price of COVID-19 tests in France, amidst rising concerns that the cost of the diagnostic test may also be limiting the number of people who are being tested in Europe – the new global epicenter of the COVID-19 pandemic. In France, […] Continue reading -> Going ‘Virtual’ In Global Health – Practices Are Changing Fast – But At An Uneven Pace 12/03/2020 Elaine Ruth Fletcher As the COVID-19 crisis seeps into financial markets, corporate board rooms, and global health systems, there may be one silver lining in an otherwise dark cloud. The 21st century era of digital health, virtual meetings and teleworking is upon us. Countries as far-flung as the Republic of Korea, Israel and even some forward-looking US health […] Continue reading -> Posts navigation Older postsNewer posts
United Nations Approves Second COVID-19 Resolution; Stresses Global Collaboration On R&D, Medicines and Equipment Access 21/04/2020 Editorial team The UN General Assembly approved a resolution Monday night calling for accelerated scientific cooperation and global coordination to hasten the “rapid development, manufacturing and distribution of diagnostics, anti-viral medicines, personal protective equipment and vaccines” needed to fight the COVID-19 pandemic. The resolution, approved in a virtual poll, also called on countries “to immediately take steps […] Continue reading -> Access To Affordable Biologics In The Context Of COVID-19: Will WHO Step Up To Its Responsibility? 14/04/2020 Chetali Rao & K M Gopakumar New Delhi, India – COVID-19 has posed unique challenges for healthcare providers across the globe, as the world has been grappling with the pandemic with no approved treatments or vaccines for the disease. Researchers are searching everywhere for drugs that may help treat or prevent the spread of the deadly virus. This has led to […] Continue reading -> COVID-19 Testing Trends – Globally & Regionally 30/03/2020 Svĕt Lustig Vijay Testing: the crux of effective outbreak responses Testing is an essential component of effective outbreak responses. Without widespread testing, we cannot know whether a disease is spreading nor take measures to appropriately respond to it. “All countries should be able to test all suspected cases, they cannot fight this pandemic blindfolded, they should know where […] Continue reading -> WHO Director General ‘Welcomes’ Costa Rica Call For Pooled Rights To COVID-19 Treatments; G-20 Pledges Broad Support To Emergency Response 26/03/2020 Elaine Ruth Fletcher World Health Organization Director General, Dr Tedros Adhanom Ghebreyesus has welcomed the call by Costa Rica’s President, Carlos Alvarado Quesada, for WHO to launch an initiative that would “pool rights to technologies that are useful for the detection, prevention, control and treatment of the COVID-19 pandemic.” “I welcome his initiative & call for pooled rights […] Continue reading -> Testing For Coronavirus – Can Latin America and Africa Build Upon The Asian Model? 25/03/2020 Svĕt Lustig Vijay & Elaine Ruth Fletcher In normal times, Diego Zapata, undersecretary in the City of Medellin’s Mobility Department, worries about how to advance better public transit systems, cycling and pedestrian networks – to get more people moving around the city. But recently, he and his boss Carlos Cadena began supporting the City’s Health Department in its scramble to reduce travel […] Continue reading -> Costa Rica Urges WHO To Lead Global Initiative For Pooled Rights To COVID-19 Diagnostics, Drugs & Vaccines 24/03/2020 Elaine Ruth Fletcher & Svĕt Lustig Vijay Costa Rica’s president, Carlos Alvarado Quesada has appealed to Dr Tedros Adhanom Ghebreyesus, Director General of the World Health Organization, to “pool rights to technologies that are useful for the detection, prevention, control and treatment of the COVID-19 pandemic”. The presidential letter dated Monday, 23 March, and co-signed by Minister of Health, Daniel Salas Peraza, […] Continue reading -> New COVID-19 Diagnostics Offer Hope – But “Broadbased Testing Not Possible” Says Roche Industry Leader 19/03/2020 Elaine Ruth Fletcher & Svĕt Lustig Vijay New high-throughput test technologies that can process thousands of COVID-19 samples a day are coming online. But the CEO of Roche Pharmaceuticals, which recently gained US Food and Drug Administration approval for a new high-volume test, asserted Thursday that “broad-based testing is simply not feasible.” Severin Schwan, Roche CEO, was speaking at a press conference […] Continue reading -> Costs Of COVID-19 Tests Could Be Limiting Scale-Up in Europe; WHO Says ‘Herd Immunity’ Approach Lacks Evidence Base 17/03/2020 Elaine Ruth Fletcher & Grace Ren A leading medicines access group in Europe has issued a protest against the high price of COVID-19 tests in France, amidst rising concerns that the cost of the diagnostic test may also be limiting the number of people who are being tested in Europe – the new global epicenter of the COVID-19 pandemic. In France, […] Continue reading -> Going ‘Virtual’ In Global Health – Practices Are Changing Fast – But At An Uneven Pace 12/03/2020 Elaine Ruth Fletcher As the COVID-19 crisis seeps into financial markets, corporate board rooms, and global health systems, there may be one silver lining in an otherwise dark cloud. The 21st century era of digital health, virtual meetings and teleworking is upon us. Countries as far-flung as the Republic of Korea, Israel and even some forward-looking US health […] Continue reading -> Posts navigation Older postsNewer posts
Access To Affordable Biologics In The Context Of COVID-19: Will WHO Step Up To Its Responsibility? 14/04/2020 Chetali Rao & K M Gopakumar New Delhi, India – COVID-19 has posed unique challenges for healthcare providers across the globe, as the world has been grappling with the pandemic with no approved treatments or vaccines for the disease. Researchers are searching everywhere for drugs that may help treat or prevent the spread of the deadly virus. This has led to […] Continue reading -> COVID-19 Testing Trends – Globally & Regionally 30/03/2020 Svĕt Lustig Vijay Testing: the crux of effective outbreak responses Testing is an essential component of effective outbreak responses. Without widespread testing, we cannot know whether a disease is spreading nor take measures to appropriately respond to it. “All countries should be able to test all suspected cases, they cannot fight this pandemic blindfolded, they should know where […] Continue reading -> WHO Director General ‘Welcomes’ Costa Rica Call For Pooled Rights To COVID-19 Treatments; G-20 Pledges Broad Support To Emergency Response 26/03/2020 Elaine Ruth Fletcher World Health Organization Director General, Dr Tedros Adhanom Ghebreyesus has welcomed the call by Costa Rica’s President, Carlos Alvarado Quesada, for WHO to launch an initiative that would “pool rights to technologies that are useful for the detection, prevention, control and treatment of the COVID-19 pandemic.” “I welcome his initiative & call for pooled rights […] Continue reading -> Testing For Coronavirus – Can Latin America and Africa Build Upon The Asian Model? 25/03/2020 Svĕt Lustig Vijay & Elaine Ruth Fletcher In normal times, Diego Zapata, undersecretary in the City of Medellin’s Mobility Department, worries about how to advance better public transit systems, cycling and pedestrian networks – to get more people moving around the city. But recently, he and his boss Carlos Cadena began supporting the City’s Health Department in its scramble to reduce travel […] Continue reading -> Costa Rica Urges WHO To Lead Global Initiative For Pooled Rights To COVID-19 Diagnostics, Drugs & Vaccines 24/03/2020 Elaine Ruth Fletcher & Svĕt Lustig Vijay Costa Rica’s president, Carlos Alvarado Quesada has appealed to Dr Tedros Adhanom Ghebreyesus, Director General of the World Health Organization, to “pool rights to technologies that are useful for the detection, prevention, control and treatment of the COVID-19 pandemic”. The presidential letter dated Monday, 23 March, and co-signed by Minister of Health, Daniel Salas Peraza, […] Continue reading -> New COVID-19 Diagnostics Offer Hope – But “Broadbased Testing Not Possible” Says Roche Industry Leader 19/03/2020 Elaine Ruth Fletcher & Svĕt Lustig Vijay New high-throughput test technologies that can process thousands of COVID-19 samples a day are coming online. But the CEO of Roche Pharmaceuticals, which recently gained US Food and Drug Administration approval for a new high-volume test, asserted Thursday that “broad-based testing is simply not feasible.” Severin Schwan, Roche CEO, was speaking at a press conference […] Continue reading -> Costs Of COVID-19 Tests Could Be Limiting Scale-Up in Europe; WHO Says ‘Herd Immunity’ Approach Lacks Evidence Base 17/03/2020 Elaine Ruth Fletcher & Grace Ren A leading medicines access group in Europe has issued a protest against the high price of COVID-19 tests in France, amidst rising concerns that the cost of the diagnostic test may also be limiting the number of people who are being tested in Europe – the new global epicenter of the COVID-19 pandemic. In France, […] Continue reading -> Going ‘Virtual’ In Global Health – Practices Are Changing Fast – But At An Uneven Pace 12/03/2020 Elaine Ruth Fletcher As the COVID-19 crisis seeps into financial markets, corporate board rooms, and global health systems, there may be one silver lining in an otherwise dark cloud. The 21st century era of digital health, virtual meetings and teleworking is upon us. Countries as far-flung as the Republic of Korea, Israel and even some forward-looking US health […] Continue reading -> Posts navigation Older postsNewer posts
COVID-19 Testing Trends – Globally & Regionally 30/03/2020 Svĕt Lustig Vijay Testing: the crux of effective outbreak responses Testing is an essential component of effective outbreak responses. Without widespread testing, we cannot know whether a disease is spreading nor take measures to appropriately respond to it. “All countries should be able to test all suspected cases, they cannot fight this pandemic blindfolded, they should know where […] Continue reading -> WHO Director General ‘Welcomes’ Costa Rica Call For Pooled Rights To COVID-19 Treatments; G-20 Pledges Broad Support To Emergency Response 26/03/2020 Elaine Ruth Fletcher World Health Organization Director General, Dr Tedros Adhanom Ghebreyesus has welcomed the call by Costa Rica’s President, Carlos Alvarado Quesada, for WHO to launch an initiative that would “pool rights to technologies that are useful for the detection, prevention, control and treatment of the COVID-19 pandemic.” “I welcome his initiative & call for pooled rights […] Continue reading -> Testing For Coronavirus – Can Latin America and Africa Build Upon The Asian Model? 25/03/2020 Svĕt Lustig Vijay & Elaine Ruth Fletcher In normal times, Diego Zapata, undersecretary in the City of Medellin’s Mobility Department, worries about how to advance better public transit systems, cycling and pedestrian networks – to get more people moving around the city. But recently, he and his boss Carlos Cadena began supporting the City’s Health Department in its scramble to reduce travel […] Continue reading -> Costa Rica Urges WHO To Lead Global Initiative For Pooled Rights To COVID-19 Diagnostics, Drugs & Vaccines 24/03/2020 Elaine Ruth Fletcher & Svĕt Lustig Vijay Costa Rica’s president, Carlos Alvarado Quesada has appealed to Dr Tedros Adhanom Ghebreyesus, Director General of the World Health Organization, to “pool rights to technologies that are useful for the detection, prevention, control and treatment of the COVID-19 pandemic”. The presidential letter dated Monday, 23 March, and co-signed by Minister of Health, Daniel Salas Peraza, […] Continue reading -> New COVID-19 Diagnostics Offer Hope – But “Broadbased Testing Not Possible” Says Roche Industry Leader 19/03/2020 Elaine Ruth Fletcher & Svĕt Lustig Vijay New high-throughput test technologies that can process thousands of COVID-19 samples a day are coming online. But the CEO of Roche Pharmaceuticals, which recently gained US Food and Drug Administration approval for a new high-volume test, asserted Thursday that “broad-based testing is simply not feasible.” Severin Schwan, Roche CEO, was speaking at a press conference […] Continue reading -> Costs Of COVID-19 Tests Could Be Limiting Scale-Up in Europe; WHO Says ‘Herd Immunity’ Approach Lacks Evidence Base 17/03/2020 Elaine Ruth Fletcher & Grace Ren A leading medicines access group in Europe has issued a protest against the high price of COVID-19 tests in France, amidst rising concerns that the cost of the diagnostic test may also be limiting the number of people who are being tested in Europe – the new global epicenter of the COVID-19 pandemic. In France, […] Continue reading -> Going ‘Virtual’ In Global Health – Practices Are Changing Fast – But At An Uneven Pace 12/03/2020 Elaine Ruth Fletcher As the COVID-19 crisis seeps into financial markets, corporate board rooms, and global health systems, there may be one silver lining in an otherwise dark cloud. The 21st century era of digital health, virtual meetings and teleworking is upon us. Countries as far-flung as the Republic of Korea, Israel and even some forward-looking US health […] Continue reading -> Posts navigation Older postsNewer posts
WHO Director General ‘Welcomes’ Costa Rica Call For Pooled Rights To COVID-19 Treatments; G-20 Pledges Broad Support To Emergency Response 26/03/2020 Elaine Ruth Fletcher World Health Organization Director General, Dr Tedros Adhanom Ghebreyesus has welcomed the call by Costa Rica’s President, Carlos Alvarado Quesada, for WHO to launch an initiative that would “pool rights to technologies that are useful for the detection, prevention, control and treatment of the COVID-19 pandemic.” “I welcome his initiative & call for pooled rights […] Continue reading -> Testing For Coronavirus – Can Latin America and Africa Build Upon The Asian Model? 25/03/2020 Svĕt Lustig Vijay & Elaine Ruth Fletcher In normal times, Diego Zapata, undersecretary in the City of Medellin’s Mobility Department, worries about how to advance better public transit systems, cycling and pedestrian networks – to get more people moving around the city. But recently, he and his boss Carlos Cadena began supporting the City’s Health Department in its scramble to reduce travel […] Continue reading -> Costa Rica Urges WHO To Lead Global Initiative For Pooled Rights To COVID-19 Diagnostics, Drugs & Vaccines 24/03/2020 Elaine Ruth Fletcher & Svĕt Lustig Vijay Costa Rica’s president, Carlos Alvarado Quesada has appealed to Dr Tedros Adhanom Ghebreyesus, Director General of the World Health Organization, to “pool rights to technologies that are useful for the detection, prevention, control and treatment of the COVID-19 pandemic”. The presidential letter dated Monday, 23 March, and co-signed by Minister of Health, Daniel Salas Peraza, […] Continue reading -> New COVID-19 Diagnostics Offer Hope – But “Broadbased Testing Not Possible” Says Roche Industry Leader 19/03/2020 Elaine Ruth Fletcher & Svĕt Lustig Vijay New high-throughput test technologies that can process thousands of COVID-19 samples a day are coming online. But the CEO of Roche Pharmaceuticals, which recently gained US Food and Drug Administration approval for a new high-volume test, asserted Thursday that “broad-based testing is simply not feasible.” Severin Schwan, Roche CEO, was speaking at a press conference […] Continue reading -> Costs Of COVID-19 Tests Could Be Limiting Scale-Up in Europe; WHO Says ‘Herd Immunity’ Approach Lacks Evidence Base 17/03/2020 Elaine Ruth Fletcher & Grace Ren A leading medicines access group in Europe has issued a protest against the high price of COVID-19 tests in France, amidst rising concerns that the cost of the diagnostic test may also be limiting the number of people who are being tested in Europe – the new global epicenter of the COVID-19 pandemic. In France, […] Continue reading -> Going ‘Virtual’ In Global Health – Practices Are Changing Fast – But At An Uneven Pace 12/03/2020 Elaine Ruth Fletcher As the COVID-19 crisis seeps into financial markets, corporate board rooms, and global health systems, there may be one silver lining in an otherwise dark cloud. The 21st century era of digital health, virtual meetings and teleworking is upon us. Countries as far-flung as the Republic of Korea, Israel and even some forward-looking US health […] Continue reading -> Posts navigation Older postsNewer posts
Testing For Coronavirus – Can Latin America and Africa Build Upon The Asian Model? 25/03/2020 Svĕt Lustig Vijay & Elaine Ruth Fletcher In normal times, Diego Zapata, undersecretary in the City of Medellin’s Mobility Department, worries about how to advance better public transit systems, cycling and pedestrian networks – to get more people moving around the city. But recently, he and his boss Carlos Cadena began supporting the City’s Health Department in its scramble to reduce travel […] Continue reading -> Costa Rica Urges WHO To Lead Global Initiative For Pooled Rights To COVID-19 Diagnostics, Drugs & Vaccines 24/03/2020 Elaine Ruth Fletcher & Svĕt Lustig Vijay Costa Rica’s president, Carlos Alvarado Quesada has appealed to Dr Tedros Adhanom Ghebreyesus, Director General of the World Health Organization, to “pool rights to technologies that are useful for the detection, prevention, control and treatment of the COVID-19 pandemic”. The presidential letter dated Monday, 23 March, and co-signed by Minister of Health, Daniel Salas Peraza, […] Continue reading -> New COVID-19 Diagnostics Offer Hope – But “Broadbased Testing Not Possible” Says Roche Industry Leader 19/03/2020 Elaine Ruth Fletcher & Svĕt Lustig Vijay New high-throughput test technologies that can process thousands of COVID-19 samples a day are coming online. But the CEO of Roche Pharmaceuticals, which recently gained US Food and Drug Administration approval for a new high-volume test, asserted Thursday that “broad-based testing is simply not feasible.” Severin Schwan, Roche CEO, was speaking at a press conference […] Continue reading -> Costs Of COVID-19 Tests Could Be Limiting Scale-Up in Europe; WHO Says ‘Herd Immunity’ Approach Lacks Evidence Base 17/03/2020 Elaine Ruth Fletcher & Grace Ren A leading medicines access group in Europe has issued a protest against the high price of COVID-19 tests in France, amidst rising concerns that the cost of the diagnostic test may also be limiting the number of people who are being tested in Europe – the new global epicenter of the COVID-19 pandemic. In France, […] Continue reading -> Going ‘Virtual’ In Global Health – Practices Are Changing Fast – But At An Uneven Pace 12/03/2020 Elaine Ruth Fletcher As the COVID-19 crisis seeps into financial markets, corporate board rooms, and global health systems, there may be one silver lining in an otherwise dark cloud. The 21st century era of digital health, virtual meetings and teleworking is upon us. Countries as far-flung as the Republic of Korea, Israel and even some forward-looking US health […] Continue reading -> Posts navigation Older postsNewer posts
Costa Rica Urges WHO To Lead Global Initiative For Pooled Rights To COVID-19 Diagnostics, Drugs & Vaccines 24/03/2020 Elaine Ruth Fletcher & Svĕt Lustig Vijay Costa Rica’s president, Carlos Alvarado Quesada has appealed to Dr Tedros Adhanom Ghebreyesus, Director General of the World Health Organization, to “pool rights to technologies that are useful for the detection, prevention, control and treatment of the COVID-19 pandemic”. The presidential letter dated Monday, 23 March, and co-signed by Minister of Health, Daniel Salas Peraza, […] Continue reading -> New COVID-19 Diagnostics Offer Hope – But “Broadbased Testing Not Possible” Says Roche Industry Leader 19/03/2020 Elaine Ruth Fletcher & Svĕt Lustig Vijay New high-throughput test technologies that can process thousands of COVID-19 samples a day are coming online. But the CEO of Roche Pharmaceuticals, which recently gained US Food and Drug Administration approval for a new high-volume test, asserted Thursday that “broad-based testing is simply not feasible.” Severin Schwan, Roche CEO, was speaking at a press conference […] Continue reading -> Costs Of COVID-19 Tests Could Be Limiting Scale-Up in Europe; WHO Says ‘Herd Immunity’ Approach Lacks Evidence Base 17/03/2020 Elaine Ruth Fletcher & Grace Ren A leading medicines access group in Europe has issued a protest against the high price of COVID-19 tests in France, amidst rising concerns that the cost of the diagnostic test may also be limiting the number of people who are being tested in Europe – the new global epicenter of the COVID-19 pandemic. In France, […] Continue reading -> Going ‘Virtual’ In Global Health – Practices Are Changing Fast – But At An Uneven Pace 12/03/2020 Elaine Ruth Fletcher As the COVID-19 crisis seeps into financial markets, corporate board rooms, and global health systems, there may be one silver lining in an otherwise dark cloud. The 21st century era of digital health, virtual meetings and teleworking is upon us. Countries as far-flung as the Republic of Korea, Israel and even some forward-looking US health […] Continue reading -> Posts navigation Older postsNewer posts
New COVID-19 Diagnostics Offer Hope – But “Broadbased Testing Not Possible” Says Roche Industry Leader 19/03/2020 Elaine Ruth Fletcher & Svĕt Lustig Vijay New high-throughput test technologies that can process thousands of COVID-19 samples a day are coming online. But the CEO of Roche Pharmaceuticals, which recently gained US Food and Drug Administration approval for a new high-volume test, asserted Thursday that “broad-based testing is simply not feasible.” Severin Schwan, Roche CEO, was speaking at a press conference […] Continue reading -> Costs Of COVID-19 Tests Could Be Limiting Scale-Up in Europe; WHO Says ‘Herd Immunity’ Approach Lacks Evidence Base 17/03/2020 Elaine Ruth Fletcher & Grace Ren A leading medicines access group in Europe has issued a protest against the high price of COVID-19 tests in France, amidst rising concerns that the cost of the diagnostic test may also be limiting the number of people who are being tested in Europe – the new global epicenter of the COVID-19 pandemic. In France, […] Continue reading -> Going ‘Virtual’ In Global Health – Practices Are Changing Fast – But At An Uneven Pace 12/03/2020 Elaine Ruth Fletcher As the COVID-19 crisis seeps into financial markets, corporate board rooms, and global health systems, there may be one silver lining in an otherwise dark cloud. The 21st century era of digital health, virtual meetings and teleworking is upon us. Countries as far-flung as the Republic of Korea, Israel and even some forward-looking US health […] Continue reading -> Posts navigation Older postsNewer posts
Costs Of COVID-19 Tests Could Be Limiting Scale-Up in Europe; WHO Says ‘Herd Immunity’ Approach Lacks Evidence Base 17/03/2020 Elaine Ruth Fletcher & Grace Ren A leading medicines access group in Europe has issued a protest against the high price of COVID-19 tests in France, amidst rising concerns that the cost of the diagnostic test may also be limiting the number of people who are being tested in Europe – the new global epicenter of the COVID-19 pandemic. In France, […] Continue reading -> Going ‘Virtual’ In Global Health – Practices Are Changing Fast – But At An Uneven Pace 12/03/2020 Elaine Ruth Fletcher As the COVID-19 crisis seeps into financial markets, corporate board rooms, and global health systems, there may be one silver lining in an otherwise dark cloud. The 21st century era of digital health, virtual meetings and teleworking is upon us. Countries as far-flung as the Republic of Korea, Israel and even some forward-looking US health […] Continue reading -> Posts navigation Older postsNewer posts
Going ‘Virtual’ In Global Health – Practices Are Changing Fast – But At An Uneven Pace 12/03/2020 Elaine Ruth Fletcher As the COVID-19 crisis seeps into financial markets, corporate board rooms, and global health systems, there may be one silver lining in an otherwise dark cloud. The 21st century era of digital health, virtual meetings and teleworking is upon us. Countries as far-flung as the Republic of Korea, Israel and even some forward-looking US health […] Continue reading -> Posts navigation Older postsNewer posts